[go: up one dir, main page]

HK1254107A1 - Anti-trailr2 antibody-toxin-conjugate and use thereof in anti-tumor therapy - Google Patents

Anti-trailr2 antibody-toxin-conjugate and use thereof in anti-tumor therapy

Info

Publication number
HK1254107A1
HK1254107A1 HK18113173.2A HK18113173A HK1254107A1 HK 1254107 A1 HK1254107 A1 HK 1254107A1 HK 18113173 A HK18113173 A HK 18113173A HK 1254107 A1 HK1254107 A1 HK 1254107A1
Authority
HK
Hong Kong
Prior art keywords
toxin
conjugate
tumor therapy
trailr2 antibody
trailr2
Prior art date
Application number
HK18113173.2A
Other languages
Chinese (zh)
Inventor
鄭德先
張書永
潘謳東
鄭超
朱婉
夏清梅
Original Assignee
煙台市和元艾迪斯生物醫藥科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 煙台市和元艾迪斯生物醫藥科技有限公司 filed Critical 煙台市和元艾迪斯生物醫藥科技有限公司
Priority to HK18113173.2A priority Critical patent/HK1254107A1/en
Publication of HK1254107A1 publication Critical patent/HK1254107A1/en

Links

HK18113173.2A 2018-10-15 2018-10-15 Anti-trailr2 antibody-toxin-conjugate and use thereof in anti-tumor therapy HK1254107A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18113173.2A HK1254107A1 (en) 2018-10-15 2018-10-15 Anti-trailr2 antibody-toxin-conjugate and use thereof in anti-tumor therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18113173.2A HK1254107A1 (en) 2018-10-15 2018-10-15 Anti-trailr2 antibody-toxin-conjugate and use thereof in anti-tumor therapy

Publications (1)

Publication Number Publication Date
HK1254107A1 true HK1254107A1 (en) 2019-07-12

Family

ID=71572044

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113173.2A HK1254107A1 (en) 2018-10-15 2018-10-15 Anti-trailr2 antibody-toxin-conjugate and use thereof in anti-tumor therapy

Country Status (1)

Country Link
HK (1) HK1254107A1 (en)

Similar Documents

Publication Publication Date Title
ZA202100195B (en) Purinone compounds and their use in treating cancer
HK1245287A1 (en) IL13RAα2 BINDING AGENTS AND USE THEREOF IN CANCER TREATMENT
SG11202011261PA (en) Urolithin a and derivatives thereof for use in therapy
SG11202107007VA (en) Antibody against human il-4ra and use thereof
IL284053A (en) Novel compounds and their use in therapy
ZA201904966B (en) Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
IL273177A (en) Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
IL281495A (en) Quinuclidine-3-one derivatives and their use in cancer treatment
ZA201904967B (en) Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
GB201511382D0 (en) Novel compounds and their use in therapy
GB201604213D0 (en) Drug combination and its use in therapy
GB201514021D0 (en) Novel Pyridines and their use in the treatment of cancer
GB201813312D0 (en) Compounds and their therapeutic use
GB201507721D0 (en) Immunosuppressive agents and their use in therapy
GB201514015D0 (en) Novel pyridazinones and their use in the treatment of cancer
EP3753579A4 (en) Anti-trailr2 antibody-toxin-conjugate and pharmaceutical use thereof in anti-tumor therapy
HUE045185T2 (en) New therapeutic compound and use in therapy
IL280555A (en) Substituted benzamides and their use in therapy
SG11202105276TA (en) Oligo-benzamide analogs and their use in cancer treatment
HK1254107A1 (en) Anti-trailr2 antibody-toxin-conjugate and use thereof in anti-tumor therapy
PL3752513T3 (en) Binuclear palladacycles and their use in the treatment of cancer
GB201814040D0 (en) Testing and therapy
EP3544622A4 (en) Peptidomimetics and their use in therapy
GB2581035B (en) Novel compounds and their use in therapy
GB201914640D0 (en) Novel compounds and their use in therapy